{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:21:05Z","timestamp":1771039265390,"version":"3.50.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,14]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Although several studies have reported that dexmedetomidine is a highly selective \u03b12-adrenergic receptor agonist that protects liver function in perioperative patients by inhibiting oxidative stress (OS) and inflammatory response, patients with type 2 diabetes mellitus (T2DM) have not been included in the previous studies. The purpose of this study was to investigate the effects of perioperative low-dose dexmedetomidine on perioperative liver function in T2DM patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This was a single-center, placebo-controlled randomized trial. Fifty-four T2DM patients scheduled for debridement of lower extremity ulcers were included in this study and randomly divided into 2 groups (n = 27 per group): the dexmedetomidine group (DEX group) and the control group (CON group). Continuous intravenous infusion of dexmedetomidine (DEX group) or normal saline (CON group) was administered from the completion of monitoring to the end of surgery. All participants received femoral and sciatic nerve block with 0.33% ropivacaine. The main result was the activity of liver enzymes (AST, ALT) reflecting liver function. The secondary results included variables reflecting blood glucose (Glu), blood lipids (TG, HDL, LDL, total cholesterol), biomarkers of OS (MDA, SOD), and systemic inflammatory response (TNF-\u03b1, IL-6).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Compared with CON group, DEX group exhibited a reduction in hemodynamic parameters, Glu, systemic inflammatory response, and liver injury indicators. OS response MDA activity was lower in DEX group than in CON group, while SOD was higher than that in CON group. The variables reflecting lipid metabolism function showed no differences between the groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion subsections:<\/jats:title>\n            <jats:p>Dexmedetomidine administered perioperatively can reduce Glu levels and protect the liver by attenuating OS injury and inflammatory response in T2DM patients without any potential risk.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000030899","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T23:06:39Z","timestamp":1665788799000},"page":"e30899","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Study on the protective mechanism of dexmedetomidine on the liver of perioperative diabetic patients: A randomized controlled trial"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9365-9856","authenticated-orcid":false,"given":"Lin","family":"Zeng","sequence":"first","affiliation":[{"name":"Shifang People\u2019s Hospital, Shifang, Sichuan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[{"name":"Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusong","family":"Liu","sequence":"additional","affiliation":[{"name":"Shifang People\u2019s Hospital, Shifang, Sichuan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lumiu","family":"Liao","sequence":"additional","affiliation":[{"name":"Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelian","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhua","family":"Dong","sequence":"additional","affiliation":[{"name":"Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/dom.12973","article-title":"Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes.","volume":"19","author":"Cusi","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.25772","article-title":"Nonalcoholic steatohepatitis clinical research network. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis.","volume":"56","author":"Loomba","year":"2012","journal-title":"Hepatology"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis.","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.dld.2010.01.016","article-title":"From the metabolic syndrome to NAFLD or vice versa?","volume":"42","author":"Vanni","year":"2010","journal-title":"Dig Liver Dis"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1476-511X-9-42","article-title":"The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).","volume":"9","author":"Liu","year":"2010","journal-title":"Lipids Health Dis"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1213\/ANE.0000000000004455","article-title":"Perioperative oxidative stress: the unseen enemy.","volume":"129","author":"Stevens","year":"2019","journal-title":"Anesth Analg"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2009.12.007","article-title":"Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells.","volume":"52","author":"Guimar\u00e3es","year":"2010","journal-title":"J Hepatol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1872-034X.2011.00814.x","article-title":"Non-alcoholic steatohepatitis-induced fibrosis: toll-like receptors, reactive oxygen species and Jun N-terminal kinase.","volume":"41","author":"Brenner","year":"2011","journal-title":"Hepatol Res"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0148607112445580","article-title":"Rhoads lecture 2011: insulin resistance and enhanced recovery after surgery.","volume":"36","author":"Ljungqvist","year":"2012","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"Suppl 2","key":"R14-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.orcp.2017.01.004","article-title":"Aerobic endurance training improves nonalcoholic fatty liver disease (NAFLD) features via miR-33 dependent autophagy induction in high fat diet fed mice.","volume":"12","author":"Ghareghani","year":"2018","journal-title":"Obes Res Clin Pract"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhep.2015.02.022","article-title":"Effect of aerobic exercise training dose on liver fat and visceral adiposity.","volume":"63","author":"Keating","year":"2015","journal-title":"J Hepatol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/hep.25548","article-title":"Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.","volume":"55","author":"Sullivan","year":"2012","journal-title":"Hepatology"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12020-019-02118-1","article-title":"Dexmedetomidine alleviates insulin resistance in hepatocytes by reducing endoplasmic reticulum stress.","volume":"67","author":"Liu","year":"2020","journal-title":"Endocrine"},{"key":"R18-20250504","first-page":"108","article-title":"The effect of dexmedetomidine on liver histopathology in a rat sepsis model: an experimental pilot study.","volume":"16","author":"Sezer","year":"2010","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"R19-20250504","doi-asserted-by":"crossref","DOI":"10.3402\/ljm.v7i0.18185","article-title":"Dexmedetomidine protects against lipid peroxidation and erythrocyte deformability alterations in experimental hepatic ischemia reperfusion injury.","volume":"7","author":"Arslan","year":"2012","journal-title":"Libyan J Med"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijsu.2012.12.003","article-title":"The protective effects of dexmedetomidine on the liver and remote organs against hepatic ischemia reperfusion injury in rats.","volume":"11","author":"T\u00fcfek","year":"2013","journal-title":"Int J Surg"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e40483","DOI":"10.5812\/aapm.40483","article-title":"The effects of dexmedetomidine administration on postoperative blood glucose levels in diabetes mellitus patients undergoing spinal anesthesia: a pilot study.","volume":"6","author":"Hui Yun","year":"2016","journal-title":"Anesth Pain Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/bja\/aeu132","article-title":"Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia: a randomized controlled trial.","volume":"112","author":"Wang","year":"2014","journal-title":"Br J Anaesth"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/ctr.12713","article-title":"Effect of dexmedetomidine on hepatic ischemia-reperfusion injury in the setting of adult living donor liver transplantation.","volume":"30","author":"Fayed","year":"2016","journal-title":"Clin Transplant"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1213\/ane.0b013e318172c47c","article-title":"Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.","volume":"106","author":"Tufanogullari","year":"2008","journal-title":"Anesth Analg"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/ALN.0b013e31825681cb","article-title":"Effect of perioperative systemic \u03b12 agonists on postoperative morphine consumption and pain intensity: systematic review and meta-analysis of randomized controlled trials.","volume":"116","author":"Blaudszun","year":"2012","journal-title":"Anesthesiology"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/BF03021622","article-title":"Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements.","volume":"53","author":"Gurbet","year":"2006","journal-title":"Can J Anaesth"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/aas.12601","article-title":"Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 1: pathophysiological considerations.","volume":"59","author":"Scott","year":"2015","journal-title":"Acta Anaesthesiol Scand"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cgh.2017.02.014","article-title":"Gastrointestinal surgery and endoscopy: recent trends in competition and collaboration.","volume":"15","author":"Baffy","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ancard.2008.02.017","article-title":"Exacerbation du stress oxydatif chez les patients diab\u00e9tiques durant une circulation extracorporelle [Oxidative stress is exacerbated in diabetic patients during cardiopulmonary bypass].","volume":"57","author":"Marty","year":"2008","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/bjs.7176","article-title":"Hepatic ischaemia-reperfusion injury from bench to bedside.","volume":"97","author":"Bahde","year":"2010","journal-title":"Br J Surg"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1213\/ANE.0000000000000185","article-title":"Dexmedetomidine reduces propofol and remifentanil requirements during bispectral index-guided closed-loop anesthesia: a double-blind, placebo-controlled trial.","volume":"118","author":"Le Guen","year":"2014","journal-title":"Anesth Analg"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"e7480","DOI":"10.1097\/MD.0000000000007480","article-title":"The effect of intraoperative dexmedetomidine on acute kidney injury after pediatric congenital heart surgery: a prospective randomized trial.","volume":"96","author":"Jo","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jclinane.2017.04.003","article-title":"The protective effects of dexmedetomidine on ischemic brain injury: a meta-analysis.","volume":"40","author":"Jiang","year":"2017","journal-title":"J Clin Anesth"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00011-017-1023-9","article-title":"Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.","volume":"66","author":"Liang","year":"2017","journal-title":"Inflamm Res"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4103\/1658-354X.177340","article-title":"Cardiac and renal protective effects of dexmedetomidine in cardiac surgeries: a randomized controlled trial.","volume":"10","author":"Ammar","year":"2016","journal-title":"Saudi J Anaesth"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4103\/2141-9248.122044","article-title":"Dexmedetomidine: an adjuvant making large inroads into clinical practice.","volume":"3","author":"Bajwa","year":"2013","journal-title":"Ann Med Health Sci Res"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.23736\/S0375-9393.17.12040-7","article-title":"Dexmedetomidine and general anesthesia: a narrative literature review of its major indications for use in adults undergoing non-cardiac surgery.","volume":"83","author":"Davy","year":"2017","journal-title":"Minerva Anestesiol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/pan.12820","article-title":"Outcomes of dexmedetomidine treatment in pediatric patients undergoing congenital heart disease surgery: a meta-analysis.","volume":"26","author":"Pan","year":"2016","journal-title":"Paediatr Anaesth"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/FPC.0b013e3283642f93","article-title":"Variation in the \u03b1(2A) adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose.","volume":"23","author":"Ghimire","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s00464-010-1474-3","article-title":"Electrocautery causes more ischemic peritoneal tissue damage than ultrasonic dissection.","volume":"25","author":"ten Broek","year":"2011","journal-title":"Surg Endosc"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12917-018-1540-y","article-title":"Effect of prolonged submaximal exercise on serum oxidative stress biomarkers (d-ROMs, MDA, BAP) and oxidative stress index in endurance horses.","volume":"14","author":"Brklja\u010da Bottegaro","year":"2018","journal-title":"BMC Vet Res"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.freeradbiomed.2013.08.174","article-title":"Free radical biology for medicine: learning from nonalcoholic fatty liver disease.","volume":"65","author":"Serviddio","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.2174\/1381612825666190116151628","article-title":"Known hepatoprotectors act as antioxidants and immune stimulators in stressed mice: perspectives in animal health care.","volume":"24","author":"de la Riva","year":"2018","journal-title":"Curr Pharm Des"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1389450116666150427155342","article-title":"Antioxidant mechanisms in nonalcoholic fatty liver disease.","volume":"16","author":"Liu","year":"2015","journal-title":"Curr Drug Targets"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10519-013-9593-y","article-title":"The genetic architecture of liver enzyme levels: GGT, ALT and AST.","volume":"43","author":"van Beek","year":"2013","journal-title":"Behav Genet"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajg.2015.06.004","article-title":"Relation of ALT and AST levels to the histopathological changes in liver biopsies of patients with chronic hepatitis C genotype 4.","volume":"16","author":"Khattab","year":"2015","journal-title":"Arab J Gastroenterol"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.exger.2013.05.059","article-title":"Prevalence and associated metabolic factors of fatty liver disease in the elderly.","volume":"48","author":"Wang","year":"2013","journal-title":"Exp Gerontol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1586\/17474124.2015.1056156","article-title":"Physiology and pathophysiology of liver lipid metabolism.","volume":"9","author":"Ponziani","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3390\/ijms19051396","article-title":"CREBH regulates systemic glucose and lipid metabolism.","volume":"19","author":"Nakagawa","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.3748\/wjg.v25.i24.3009","article-title":"Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease.","volume":"25","author":"Mato","year":"2019","journal-title":"World J Gastroenterol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:28:25Z","timestamp":1746336505000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":51,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030899","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]}}}